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Background. Multiple sclerosis (MS) is frequently associated with cognitive and behavioural deficits. A growing number of studies
suggest an impact of MS on decision-making abilities. The aim of this systematic review was to assess if (1) performance of MS
patients in decision-making tasks was consistently different from controls and (2) whether this modification was associated with
cognitive dysfunction and emotional alterations. Methods. The search was conducted on Pubmed/Medline database. 12 studies
evaluating the difference betweenMS patients and healthy controls using validated decision-making tasks were included. Outcomes
considered were quantitative (net scores) and qualitative measurements (deliberation time and learning from feedback). Results.
Quantitative and qualitative decision-making impairment in MS was present in 64.7% of measurements. Patients were equally
impaired in tasks for decision-making under risk and ambiguity. A correlation to other cognitive functions was present in 50%
of cases, with the highest associations in the domains of processing speed and attentional capacity. Conclusions. In MS patients,
qualitative and quantitative modifications may be present in any kind of decision-making task and can appear independently of
other cognitive measures. Since decision-making abilities have a significant impact on everyday life, this cognitive aspect has an
influential importance in various MS-related treatment settings.
1. Introduction
Decisions are a challenge we all face daily. Deficits in the
ability to make decisions can have far reaching consequences
on all aspects of our lives, such as finances and social interac-
tions.
Decision-making is a complex behavioural process re-
quiring multiple steps (see Ernst and Paulus [1] for a com-
prehensive review).
First, by realizing that a decisionmust be taken, individu-
als initiate an internal process that starts with the definition of
the nature of the decision that has to bemade. Second,mental
search and imaginative abilities are crucial. If the probabilities
for possible outcome scenarios are given but the outcome
is not, then subjects have to decide under risk. In case that
neither outcome, nor the probabilities for specific outcomes
are known, decisions are taken under ambiguity. In a next
step, the collected information is weighted against emotions.
Hence, decision-making is driven by cognitive as well as
emotional components [2]. Finally, once a decision has led
to unfavourable results, it has to be evaluated concerning its
long-term consequences. Thus, besides the mere decisional
components (e.g., selecting and weighing) attentional, mnes-
tic, executive, and prospective thinking and learning abilities
are required, for example, for the capacity to modify or to
adapt to wrong choices. Decisions under ambiguity show
little correlation with executive functions [3] and an asym-
metrical dependency on working memory. This means that
isolated deficits in decision-making with preserved working
memory performance are possible while impaired working
memory consistently leads to a deficit in decision-making [4].
In contrast to this, impairments in tasks with decisions under
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risk (such as dice games) have been correlated to specific
executive functions such as categorization, monitoring, and
using of feedback for current decisions [5, 6].
Emotional components also exert a significant influence
in decision-making performance. Damasio’s somatic marker
hypothesis [7], which introduces an emotional component
to the decision-making process states that, faced with a
decision, a first selection of the most advantageous choices is
made by balancing positive and negative “somatic markers,”
measured by skin conductance reaction [8] in gambling tasks.
Emotional markers apply to every decision, such as choosing
clothes, profession, or accepting a medical treatment. How-
ever, most paradigms come from neuroeconomy.
Given this cognitive and emotional complexity, the pro-
cess of decision-making has been associated with a large cor-
ticosubcortical network encompassing different structures of
the ventral prefrontal cortex [8], specifically the ventromedial
[2] areas, and the orbitofrontal cortex [9, 10], but also the
amygdala and the striatal system [11].
Multiple sclerosis (MS) is a demyelinating disease of the
central nervous system, which affects both white and grey
matter [12]. Cognitive domains such as attention, informa-
tion-processing speed and efficiency, executive functioning,
and long-termmemory are known to be affected in 43–70%of
all patients, in early as well as in late stages of the disease (for
review see [13, 14]). Modifications of emotional experience
and verbalization have been shown in MS patients [15].
Most recently, a growing field of research has accumulated,
reporting deficits or alterations in decision-making in MS
patients [16–26].
As MS patients have to make decisions about their
treatment and lifestyle, it is of eminent importance to know,
whether and if so, how their decision-making abilities may be
subjected to changes due to their disease.
The aim of this paper is to review the existing literature on
decision-making in MS patients and to answer the following
questions.
(1) Is modified decision-making in MS patients a con-
sistent finding in pertinent studies? If so, what is the nature
of this modification? Is there a difference between decision-
making performance under risk and under ambiguity? (2)
Is modified decision-making associated with cognitive dys-
function in particular domains or altered emotional reac-
tions?
2. Methods
2.1. Article Selection. Between 1 and 13May 2015, we searched
the Medline/Pubmed database for articles published from
2004 to 2015, using the keywords: “Decision-making”, “Mul-
tiple Sclerosis”, “Cognition”, “Gambling” and “Dice”. We
selected for a thorough analysis all original studies that
fitted our inclusion criteria. Additional papers that fitted the
inclusion criteria and were published after the search period
were also included.
2.2. Inclusion Criteria. To qualify for inclusion in our anal-
ysis, the studies had to fulfil the following criteria: (i) they
had to comprise ten or more participants in the MS patients
group. (ii) The patient’s decision-making performances had
to be compared against a healthy control group without
neurological or psychiatric disorders. (iii) The assessment of
decision-making abilities was performed with explicitly
described and clinically validated tasks.
2.3. Data Collection and Analysis. We recorded the results
of the decision-making tests and, whenever assessed in the
study, associated values in general cognition or executive
performance and mood and behavioural tests. When several
decision-making tests were applied in one study, each mea-
surement was considered separately. Differences in DM per-
formance between MS patients and controls were considered
significant if the results of the reported net scores were lower
by adopting an error probability of 𝑝 < 0.05 in the patients
group compared to healthy controls. Where no net scores
were stated differences in qualitative measurements such as
deliberation time and risk adjustments were considered for
the description of global performance. The same qualitative
measures were considered to unravel possible differences in
the learning process between MS patients and controls.
2.4. Tasks Used in the Selected Clinical Studies
2.4.1. Decision under Risk Tasks. In the Game of Dice Task
(GDT) [5] the subjects have to maximize the winnings by
guessing which number a virtual dice will show next. They
can predict one number, in which case possible gains but
also losses are high. They can reduce the risk by choosing
a combination of up to four numbers, which increases
the possibility of winning but also decreases the possible
gains and losses. Choices of one or two dice are considered
risky/disadvantageous (less than 50% winning probabilities);
choices of three or four numbers are considered advanta-
geous. In total, the die is thrown 18 times.This task was devel-
oped to minimise the ambiguity of the gambling situation
by establishing explicit and stable rules. Quality of decision-
making is measured using a total net score calculated by
extracting the number of disadvantageous choices from the
number of advantageous ones.
In the Cambridge Gambling Task (CGT) [10], subjects
have to maximize their winnings by guessing if a token is
hidden under a red or a blue box. While the total number
of boxes remains constant, the ratio of the colours varies
from round to round and so do the associated stakes.
Correct guesses are rewarded; wrong choices punished with
an amount chosen beforehand by the participant. The main
outcome is the proportion of trials in which the participant
chooses the more likely outcome. Other measured values
are deliberation time for each decision, amount bet, an
impulsivity index, and the risk adjustment (the adjustment of
bet amount to the stakes). In some studies, the total of blocks
ending up in bankruptcy was also calculated.
In the Wheel of Fortune task (WOF) [29], two wheels
appear on a computer screen, each of them is divided into two
sectors. Each sector is associated with a positive or negative
value, corresponding to the amount added or subtracted from
the total winnings, should the needle, after rotating, stop in
this sector. The sectors size indicates the probability of the
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Table 1: Tests used to assess cognitive domains other than decision-making.
Executive functioning IQ Processing speed andattention capacity Memory
Shifting:
(i) Trail Making Test B
(TMT-B)
National Adult reading
test (NART, premorbid
IQ)
Symbol Digit Modalities
Test (SDMT)
Rey auditory verbal
learning test (RAVLT)
Inhibition
(i) Hayling sentence
completion
(ii) Stroop time
Wechsler Adult
Intelligence Scale-III
(WAIS-II, current IQ)
Trail Making Test A
(TMT-A)
Selective reminding test
(SRT)
Updating:
(i) Verbal fluency (letter
and category)
(ii) Digit span backwards
9-hole Pegboard
Adult Memory and
Information Processing
Battery (AMIPB
story/figure)
Planning:
(i) Wisconsin Card
sorting test
(ii) Modified card
sorting test (MCST)
(iii) Stockings of
Cambridge (SOC)
(iv) Tower of Hanoi
(v) Tower of London
Digit span forward 10/36 spatial recalling
Behavioural Assessment
of the Dysexecutive
Syndrome (BADS)
Paced Auditory Serial
Addition (PASAT) 7/24 spatial recalling
(i) Raven’s coloured
progressive matrices
outcome. The subjects have to choose one wheel. The aim
is, again, to maximize the winnings. The quality of decision-
making was assessed by themaximization of expected values.
Other measurements included the emotional evaluation of
outcomes and the effect of anticipating disappointment and
regret.
2.4.2. Decisions under Ambiguity Tasks. In the Iowa Gam-
bling Task (IGT) [30], the subjects are presented with four
decks of cards (decks A–D). They have to turn the cards,
one by one. Cards from the decks A and B are consistently
associated with a winning of 100 dollars or more in play
money and decks C and D with lower incomes (in the
order of 50 dollars). After having turned a certain number
of cards, the subjects additionally receive irregularly an
apparently unpredictable punishment. In fact high winnings
are associated with even higher punishment, resulting in total
losses, whereas low winnings are associated with even lower
punishment, thus resulting in a positive balance. A total of
100 choices are to be made. These rules are not explained to
the subjects, who have to gradually identify the nature of the
decks and switch to choosing the advantageous cards. The
index of performance is obtained by subtracting the number
of disadvantageous choices (cards from blocks A and B) from
the advantageous choices (cards from blocks C and D). For
the net score, all trials are considered. Some studies also
analysed the progression of choices by dividing the task into 5
trials, each consisting of 20 choices and calculating the index
of performance for each trial separately.
2.4.3. Cognitive Function Tasks. In the included studies, the
following tests were used to assess cognitive domains other
than decision-making (Table 1).
2.4.4. Assessment of Mood, Behaviour, and Quality of Life.
The following tests were used to assess the subject’s mood,
behaviour, and quality of life: Dysexecutive Questionnaire
(DEX); Iowa Scale of Personality Change (ISPC); Fatigue:
Fatigue Assessment Inventory (FAI); Hospital Anxiety and
Depression Scale (HAD); Handicap: LondonHandicap Scale;
Self-Perceived Health (SEP-59); Beck Depression Inventory
(BDI).
2.5. Statistical Analysis. The proportion of studies showing a
significant difference in net decision-making scores between
MSpatients and controls among the total number of reviewed
studies is presented in raw data, 𝑧-score, and percentage. For
the comparison of results between two groups (tasks under
risk and under ambiguity, EDSS </>3), the 𝜒2 test was used.
3. Results
3.1. Sample Characteristics. A total of 12 studies matched the
inclusion criteria and were therefore considered for the study.
Sample size varied from 𝑛 = 12 to 𝑛 = 165MS/Clinically Iso-
lated Syndrome (CIS) patients with anmeanEDSS (expanded
disability status scale [31]) ranging from 1.03 to 7.2. Table 2
shows clinical and neuropsychological data of the patient
groups.
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33.4%66.6%
Preserved
Impaired
(a)
Preserved
Impaired
63.6%
34.4%
(b)
50%
50%
Correlation with cognitive
performance
No correlation with cognitive
performance
(c)
Figure 1: Proportions of preserved and impaired performance in decisions under risk tasks (a) and under ambiguity (b). Proportion of
measurements showing a correlation to the performance in other cognitive tasks (c).
3.1.1. Decision-Making in MS and CIS Patients. In total, 17
tasks for decision-making (DM) were measured and in each
study the performance was compared to healthy controls.
Performance of MS patients was impaired compared to the
healthy controls in 11/17 tasks (64.7%) and preserved in 6/17
tasks (35.3%).
(a) Decision-Making under Risk in MS Patients. As described
above, the tasks GDT, CGT, and WOF are considered to test
decision-making under risk. In total, decision-making under
risk was impaired in MS patients in 4/6 (66.6%) over all
analysed measurements (cf. Figure 1(a)).
(b) Decision-Making under Ambiguity. All analysed studies
reported a total of 11measurements of decision-making under
ambiguity, all of them using the Iowa Gambling Task. Based
on the net score, performance ofMS patients was impaired in
7/11 (63.6%) of the tests (cf. Figure 1(b)).
𝜒2 showed no difference between the performance of MS
patients in the two task groups (under ambiguity/under risk)
(𝑝 = 0.79).
(c) Qualitative Changes in DM. Qualitative analysis of DM
included mostly two groups of measurements: adjustment
to feedback and deliberation time. Subjects were considered
to adjust to feedback when they presented a learning curve,
moving gradually away from risky choices toward safer ones
in the course of the trials. In 2 of 4 studies using the IGT MS
patients showed a lower learning-index (50%). In another 5
IGT-based measurements, where the index was not explicitly
calculated, MS patients had a learning curve that was less
steep than HCs or showed a more pronounced impairment
in the last blocks of the IGT, indicating slowed learning from
feedback.
Moreover, MS patients had longer deliberation times in
two of 3 altogether studies.
In total, in 11/17 (64.7%) of cases, qualitative changes in
DM were seen in MS patients compared to HCs.
3.1.2. Association between Decision-Making and Cognitive
Dysfunction or Physical Disability. Nine studies including 12
separate tasks of DM assessed correlations of performance in
other cognitive domainswith results in theDM tasks (Tables 1
and 2). A total of 6/12 (50%) of tasks showed a correlationwith
any kind of cognitive performance (Table 3). More precisely,
4/12 (33.3%), correlated with a measurement of executive
functioning, whereas processing speed and attention capacity
were correlated with DM performance in 5/9 times (56%).
DM under ambiguity correlated in 2/11 (18%) cases with
measurements of other cognitive functions, DM under risk
in 9/16 (56%) (Table 4). 𝜒2 showed a significant difference
between the two types of DM (𝑝 = 0.04792), suggesting that
DMunder risk ismore sensitive to cognitive impairment than
DM under ambiguity.
Concerning physical disability, patient groups with a
median/mean EDSS lower than 3 performed worse than HC
in 54.5% (6/11) of decision-making tasks. In patients with
EDSS ≥ 3, 80% (4/5) of DM scores were worse in MS patients
than HC (𝜒2 between both groups being nonsignificant; 𝑝 <
0.33).
In tasks measuring DM under risk, all tasks in patients
with an EDSS > 2 showed an impairment. On the other hand,
DM under ambiguity (IGT) was preserved even in a patients
group with a mean EDSS of 7.
3.1.3. Association between Decision-Making and Emotional
Reaction. Emotional reactivity wasmeasured using skin con-
duction reactivity (SCR) in only two studies. SCR was
reduced in one study reporting DMunder ambiguity [20] but
preserved in the other, where DM was taken under risk [26].
Reduced expression of negative emotion, such as disappoint-
ment and regret, was stated in MS patients when confronted
with negative outcomes [26].
4. Discussion
The aim of our study was to evaluate the decision-making
(DM) abilities of patients with MS. Given the complexity of
the process, we further considered the relationship between
DM and overall cognitive performance as well as emotional
components to the DM process. On the basis of 12 eligible
studies, we found decreased DM performance in the MS
group in 64.7%. Our results indicate an overall alteration of
DM abilities in MS patients, since both DM under ambiguity
and DM under risk were affected. DM under risk was altered
in 67% and DM under ambiguity in 64% of measurements in
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Table 3: Decision-making performance in MS patients compared to HCs and correlations with other cognitive domains.
Study Measurement Altered DM net scores(𝑧-score)
Qualitative changes in
DM
Correlation of DM with
any measure of cognition
Farez et al. (2014) GDT + (2.76) − +
IGT net + (4.39) + nm
Simioni et al. (2012) WOF + + −
CGT − (3.75) + +
Muhert et al. (2014) CGT + + +
Radomski et al. (2015) GDT + (0.75) − +
Kleeberg et al. (2004) IGT net − (0.3) + +
Cogo et al. (2014) GDT − (0.22) − −
IGT net − (0.31) − +
Simioni et al. (2008) IGT net − (0.1) − −
Garc´ıa-Molina et al.
(2008) IGT + (1.02) + nm
Nagy et al. (2006) IGT (ABCD) + + −
IGT (EFGH) + + −
Roca et al. (2008) IGT + (0.75) + nm
Garc´ıa-Molina et al.
(2009)
IGT (SP) − (0.38) + nm
IGT (PP) + (1.02) + nm
Azca´rraga-Guirola et al.
(2016) IGT + (0.7) − −
Total 11/17 11/17 6/12
+: present, −: absent, nm: not measured, SP: secondary progressive, PP: primary progressive, numbers in brackets: 𝑧-values.
Table 4: Proportion of studies showing a correlation between DM tasks and other cognitive domains.
Executive function IQ Processing speed and attention capacity Memory Total
IGT 1/6 - 1/4 0/1 2/11
GDT 1/3 - 2/3 1/3
9/16WOF 0/1 - - -
CGT 2/2 0/1 2/2 1/2
Total 4/12 (33%) 0/1 (0%) 5/9 (56%) 2/6 (33%)
MS patients with no statistical difference in the performance
between the two task groups.
Further analysis revealed also differences between MS
patients and HCs in qualitative measurements such as reac-
tion times or reaction to feedback through most tasks (11/17),
even when the groups reached comparable net results. Only
one study [24] showed a preserved learning curve in the IGT.
Notably, the subjects in this study had a low EDSS and short
disease duration. These findings suggest a gradual decline of
the learning process over the course of the disease. Hence a
qualitative evaluation of the learning process might reflect a
more sensitive rating of DM performance than the net scores
do.
DM performance in general correlated with ventricular
size as well as white matter lesions [21, 23] and is influenced
by lesions in the temporal region [28].
Functional studies found decision-making-related activ-
ity in the insular, prefrontal, and frontal lobes as well as the
cingulate gyrus and caudate nuclei [21, 32]. More specifically,
the stage of deliberation and choice-making correlated with
activity of a large network, involving themedial and dorsolat-
eral prefrontal lobe, middle frontal gyrus, anterior cingulate,
caudate [21], and insula [32].
Feedback processing and risk adjustment were associated
with the hippocampus [21] and orbitofrontal areas [32].
With our results confirming an alteration of DM per-
formance in a majority of MS patients, the question on the
underlying mechanism arises. In IGT, where the index of
risky choices is obtained by subtracting the number of disad-
vantageous or “risky” choices from the advantageous choices,
a lower index indicates risk-seeking behaviour. The results
here consistently pointed to MS patients showing a risk-
seeking tendency. This could be due to hypersensitivity to
reward or to a reduced ability toweigh immediate gain against
long-term outcome, a so-called “myopia for the future.” The
study by Nagy and colleagues [22] addressed this question
specifically. They used two different versions of the IGT:
the standard ABCD version and an adapted EFGH ver-
sion, where subjects receive punishment with each card but
varying reward. Impaired performance in the standard IGT
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indicates increased sensitivity to reward, whereas in the
EFGH version it points to behaviour of risk avoidance. MS
patients showed impaired decision-making in both versions
of the task, suggesting a general deficit to evaluate long-term
outcomes in DM under ambiguity.
However, MS patients have demonstrated risk-aversive
behaviour in tasks using DM under risks paradigms, such
as the WOF [26] and longer deliberation time in the CGT
[21, 26]. Such results, specifically found in these tasks, have
been interpreted as both adaptive changes in the face of
cognitive deficits and/or alterations in emotional reactiv-
ity due to MS, when a decision has to be taken under
risk.
We could not demonstrate an impact of severity of MS,
as measured by the EDSS on DM performance, possibly
because of an insufficient size. However, qualitative analysis,
comparing groupswith an EDSS of under and over 3, suggests
an influence of disease progression. On the other hand, one
group with an EDSS of 7 [16] showed a preserved IGT per-
formance. Notably, this group consisted of patients with a
secondary progressive course of MS, raising the question of
the influence of the disease course on DM abilities. Only
three studies assessedDMperformance between differentMS
courses and came to contradictory conclusions. However,
when looking at measurements of patients with a relapsing
remitting MS only (𝑛 = 12 in 8 different studies), the
proportions of failures were comparable to the MS group as a
whole (8/12 impaired, 66.6%).
A correlation of a high relapse rate with DMperformance
has been described [24]. This could be an explanation for
the inconsistent performance pattern, especially regarding
the correlation with EDSS and IGT. Patient groups with low
EDSS scoresmight also include patients withmore aggressive
form of MS, presenting a higher relapse rate and there-
fore potentially associated with DM alterations despite low
functional impairment. Also, in one study, higher EDSS
correlated with higher anxiety and less impaired IGT score
[20]. Possibly, the anxiety inmore affected patients led to risk-
aversive behaviour, thus attenuating risk-taking behaviour on
performance in the IGT.
As stated in the introduction, cognitive and emotional
functionalities are important for a normal performance in
DM tasks. These aspects will now be discussed separately.
4.1. Association with Cognition. DM tasks require attentional,
mnestic, executive, and prospective thinking and learning
abilities. Consequently, in 50% (6/12) of the evaluated studies,
the results correlated with the performance in other cognitive
domains, mostly with processing speed and attention capac-
ity. Hence, the evaluated studies corroborate previous find-
ings, where cognitive dysfunctions had a negative, though not
exclusive impact on DM.
Of the DM tasks, the IGT was least correlated with other
cognitive measures (see Table 4).This is in line with previous
results, showing DM under ambiguity less dependent on
general cognitive performance than DM under risk [3].
4.2. Emotion. The emotional component of the DM process
was assessed in only a few of the studies and a quantitative
analysis was therefore not possible. We will, however, do a
qualitative evaluation.
In the IGT, healthy subjects generate anticipatory SCR
before choosing cards from a “risky” deck even before con-
sciously understanding the rules of the game, thus reflecting
their somatic state activation. This part of the IGT has been
called the “hunch period” [33]. Kleeberg and colleagues
[20] described reduced SCR and a later switch to good
decks in MS patients with an EDSS > 2, possibly skipping
“hunch” period and switching to gooddecks only after overtly
understanding the rules. This would indicate a disruption of
the emotional component of a DM process. Another study
reported reduced expression of negative emotions after coun-
terfactual information but normal SCRs in DM under risk
[26]. Possible explanations for the divergence between the
SCR results in the two studies are the differences in EDSS and
disease duration. As discussed for general DM performance,
emotional components of DM might also decline during the
disease course. Alternatively, the difference could be due to
DM under ambiguity being more closely associated with the
emotional aspects of DM, while DM under risk seems more
related to other cognitive functions. Further research should
be conducted to investigate this possible dissociation between
the two forms of DM.
Fatigue was not mentioned as a possible correlated symp-
tom in most of the studies. The only two studies assessing
it stated elevated fatigue levels in MS patients compared to
HCs [23, 24]. However, no study correlated fatigue with DM
performance. Fatigue is a common symptom inMS and likely
to influence the performance on cognitive tests, especially
when sustained mental effort is required [13]. It was only
rarely assessed in the studies and neither was always stated
if the DM task were administered before or after the often
extensive neuropsychological testing.Therefore, an influence
of fatigue on the results of the DM tasks cannot be exclud-
ed.
There are a certain number of limitations to this paper.
Group sizes as well as demographic constellation varied
across the included studies. Also, there were methodological
differences in the studies regarding the tests administered and
the outcomes measured. However, the aim of this systematic
review being a descriptive overview on existing literature has
in our eyes been achieved.
5. Conclusions
Taken together, our review of the existing studies suggests
the presence of qualitative as well as quantitative changes
in decision-making abilities in the majority (2/3rd) of MS
patients by showing altered decision-making performance
in tasks under risk and under ambiguity. Decision-making
performance, especially under risk, might be influenced by
disease progression, but performance by MS patients was
independent of other cognitive measures in half of the
analysed decision-making tasks.Thus, decision-making is an
aspect of cognition to be kept in mind by doctors and nurses
treating MS patients, even in the absence of other cognitive
deficits.
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